Microbot Medical Stock Performance
| MBOT Stock | USD 2.06 0.09 4.19% |
On a scale of 0 to 100, Microbot Medical holds a performance score of 3. The company secures a Beta (Market Risk) of 2.02, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Microbot Medical will likely underperform. Please check Microbot Medical's jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to make a quick decision on whether Microbot Medical's current price movements will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Microbot Medical are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Microbot Medical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.19) | Five Day Return (5.50) | Year To Date Return (2.37) | Ten Year Return (99.61) | All Time Return (100.00) |
Last Split Factor 1:15 | Dividend Date 2018-09-05 | Last Split Date 2018-09-05 |
1 | DNB Asset Management AS Boosts Stock Position in Microbot Medical Inc. MBOT | 11/26/2025 |
2 | Microbot Medical Earns Buy Rating from Analysts at Roth Capital - MarketBeat | 12/05/2025 |
3 | Microbot Medical Inc CY9D Stock Analysis and Forecast - Options Trading Strategies Superior Trading Portfolio - earlytimes.in | 12/22/2025 |
4 | Microbot Medical Continues its 2025 Momentum Announces Key 2026 Milestones | 01/12/2026 |
5 | Microbot Medicals LIBERTY Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference | 02/12/2026 |
6 | Acquisition by Rachel Vaknin of 105000 shares of Microbot Medical at 2.1 subject to Rule 16b-3 | 02/18/2026 |
7 | Microbot Medicals LIBERTY Endovascular Robotic System Continues to Expand Market Visibility Being Featured at an Industry Leading Innovation Conference | 02/19/2026 |
| Begin Period Cash Flow | 2.5 M | |
| Total Cashflows From Investing Activities | 1.5 M |
Microbot Medical Relative Risk vs. Return Landscape
If you would invest 192.00 in Microbot Medical on November 24, 2025 and sell it today you would earn a total of 14.00 from holding Microbot Medical or generate 7.29% return on investment over 90 days. Microbot Medical is currently generating 0.2295% in daily expected returns and assumes 4.9404% risk (volatility on return distribution) over the 90 days horizon. In different words, 44% of stocks are less volatile than Microbot, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Microbot Medical Target Price Odds to finish over Current Price
The tendency of Microbot Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.06 | 90 days | 2.06 | about 54.19 |
Based on a normal probability distribution, the odds of Microbot Medical to move above the current price in 90 days from now is about 54.19 (This Microbot Medical probability density function shows the probability of Microbot Stock to fall within a particular range of prices over 90 days) .
Microbot Medical Price Density |
| Price |
Predictive Modules for Microbot Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Microbot Medical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Microbot Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Microbot Medical is not an exception. The market had few large corrections towards the Microbot Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Microbot Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Microbot Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.04 | |
β | Beta against Dow Jones | 2.02 | |
σ | Overall volatility | 0.19 | |
Ir | Information ratio | 0.01 |
Microbot Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Microbot Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Microbot Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Microbot Medical had very high historical volatility over the last 90 days | |
| Net Loss for the year was (11.44 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Microbot Medical currently holds about 9.29 M in cash with (8.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31. | |
| Microbot Medical has a poor financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Microbot Medicals LIBERTY Endovascular Robotic System Continues to Expand Market Visibility Being Featured at an Industry Leading Innovation Conference |
Microbot Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Microbot Stock often depends not only on the future outlook of the current and potential Microbot Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Microbot Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.6 M | |
| Cash And Short Term Investments | 5.5 M |
Microbot Medical Fundamentals Growth
Microbot Stock prices reflect investors' perceptions of the future prospects and financial health of Microbot Medical, and Microbot Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Microbot Stock performance.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.2 | ||||
| Current Valuation | 66.47 M | ||||
| Shares Outstanding | 67.16 M | ||||
| Price To Earning | (3.42) X | ||||
| Price To Book | 1.86 X | ||||
| EBITDA | (11.35 M) | ||||
| Net Income | (11.44 M) | ||||
| Cash And Equivalents | 9.29 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 111 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 1.19 X | ||||
| Cash Flow From Operations | (8.83 M) | ||||
| Earnings Per Share | (0.45) X | ||||
| Market Capitalization | 138.35 M | ||||
| Total Asset | 6.03 M | ||||
| Retained Earnings | (90.94 M) | ||||
| Working Capital | 3.36 M | ||||
| Current Asset | 15.21 M | ||||
| Current Liabilities | 9.83 M | ||||
About Microbot Medical Performance
Assessing Microbot Medical's fundamental ratios provides investors with valuable insights into Microbot Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Microbot Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -827.1 K | -868.4 K | |
| Return On Tangible Assets | (2.18) | (2.07) | |
| Return On Capital Employed | (3.74) | (3.56) | |
| Return On Assets | (2.18) | (2.07) | |
| Return On Equity | (2.92) | (2.77) |
Things to note about Microbot Medical performance evaluation
Checking the ongoing alerts about Microbot Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Microbot Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Microbot Medical had very high historical volatility over the last 90 days | |
| Net Loss for the year was (11.44 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Microbot Medical currently holds about 9.29 M in cash with (8.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31. | |
| Microbot Medical has a poor financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Microbot Medicals LIBERTY Endovascular Robotic System Continues to Expand Market Visibility Being Featured at an Industry Leading Innovation Conference |
- Analyzing Microbot Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Microbot Medical's stock is overvalued or undervalued compared to its peers.
- Examining Microbot Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Microbot Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Microbot Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Microbot Medical's stock. These opinions can provide insight into Microbot Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.